IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 119 filers reported holding IMMUNITYBIO INC in Q2 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,684,788 | -43.7% | 1,588,632 | -7.3% | 0.00% | -100.0% |
| Q2 2023 | $4,764,678 | +278.3% | 1,713,913 | +147.7% | 0.00% | – |
| Q1 2023 | $1,259,391 | -69.4% | 691,973 | -14.7% | 0.00% | -100.0% |
| Q4 2022 | $4,114,300 | -19.4% | 811,499 | -21.0% | 0.00% | 0.0% |
| Q3 2022 | $5,107,000 | +41.9% | 1,027,466 | +6.2% | 0.00% | 0.0% |
| Q2 2022 | $3,600,000 | -45.2% | 967,519 | -17.4% | 0.00% | 0.0% |
| Q1 2022 | $6,569,000 | -67.3% | 1,171,040 | -64.6% | 0.00% | – |
| Q4 2021 | $20,092,000 | +14.2% | 3,304,652 | +82.9% | 0.00% | -100.0% |
| Q3 2021 | $17,596,000 | -28.8% | 1,806,644 | +4.4% | 0.00% | -50.0% |
| Q2 2021 | $24,710,000 | -43.6% | 1,730,381 | -6.2% | 0.00% | -42.9% |
| Q1 2021 | $43,787,000 | – | 1,844,427 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 251,556 | $1,387,000 | 1.70% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,322 | $1,567,000 | 0.89% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,668,000 | 0.54% |
| ALLEN HOLDING INC /NY | 687,571 | $3,417,000 | 0.54% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $479,000 | 0.21% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $1,033,000 | 0.17% |
| Clearwater Capital Advisors, LLC | 185,911 | $924,000 | 0.13% |
| WEALTH EFFECTS LLC | 28,500 | $142,000 | 0.09% |
| Virtus ETF Advisers LLC | 35,048 | $174,000 | 0.07% |
| Vident Investment Advisory, LLC | 195,127 | $969,000 | 0.03% |